Angelini Ventures

Angelini Ventures company information, Employees & Contact Information

Angelini Ventures is the venture capital arm of Angelini Industries funded with a €300 million capital commitment to build and invest in companies that develop innovative ideas and solutions in biotechnology, digital health and life sciences. Angelini Ventures invests across Europe and North America with a focus on brain health and consumer segments such as women, children and the elderly. The company is headquartered in Rome with a global team spread across Europe, Asia and the US to provide global perspective and capabilities.

Company Details

Employees
31
Address
Rome, It
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
Keywords
Rome.
HQ
Rome
Looking for a particular Angelini Ventures employee's phone or email?

Angelini Ventures Questions

News

Angelini Ventures Leads €12 Million Follow-On Investment in Serenis, a Fast-Growing Digital Mental and Physical Health Company - Yahoo Finance

Angelini Ventures Leads €12 Million Follow-On Investment in Serenis, a Fast-Growing Digital Mental and Physical Health Company Yahoo Finance

Angelini Ventures Deepens Commitment to CoMind, a Neurotech - GlobeNewswire

Angelini Ventures Deepens Commitment to CoMind, a Neurotech GlobeNewswire

Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders - Yahoo Finance

Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders Yahoo Finance

Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director - GlobeNewswire

Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director GlobeNewswire

Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy - PR Newswire

Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy PR Newswire

Reinforcement for Angelini Ventures - European Biotechnology Magazine

Reinforcement for Angelini Ventures European Biotechnology Magazine

Angelini Ventures Invests into $39 Million Series A - GlobeNewswire

Angelini Ventures Invests into $39 Million Series A GlobeNewswire

Angelini Ventures among supporters of $45 million Nuevocor round - The Pharma Letter

Angelini Ventures among supporters of $45 million Nuevocor round The Pharma Letter

Italy’s angels & incubators and venture capital weekly roundup. News from CoMind, Angelini Ventures, Plural, LocalGlobe, Caracol, Ombes Capital, Move Capital Fund, CDP, Primo Capital, Eureka! Venture, Neva, and more – BeBeez International - BeBeez International

Italy’s angels & incubators and venture capital weekly roundup. News from CoMind, Angelini Ventures, Plural, LocalGlobe, Caracol, Ombes Capital, Move Capital Fund, CDP, Primo Capital, Eureka! Venture, Neva, and more – BeBeez International BeBeez International

Angelini Ventures leads €10 million Series A financing in Vantis, a Digital Care Innovation company - GlobeNewswire

Angelini Ventures leads €10 million Series A financing in Vantis, a Digital Care Innovation company GlobeNewswire

Angelini Ventures co-leads €20m Series A to advance RNA therapeutics for neurological disorders - European Biotechnology Magazine

Angelini Ventures co-leads €20m Series A to advance RNA therapeutics for neurological disorders European Biotechnology Magazine

Angelini Ventures Co-Leads $45 Million Series B Financing - GlobeNewswire

Angelini Ventures Co-Leads $45 Million Series B Financing GlobeNewswire

Angelini Ventures co-leads €20 million Series A financing - GlobeNewswire

Angelini Ventures co-leads €20 million Series A financing GlobeNewswire

Adcytherix Raises EUR 105M Series A to Accelerate - GlobeNewswire

Adcytherix Raises EUR 105M Series A to Accelerate GlobeNewswire

Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized cancer vaccines - GlobeNewswire

Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized cancer vaccines GlobeNewswire

Angelini Industries Launches Angelini Ventures € 300 Million Commitment - GlobeNewswire

Angelini Industries Launches Angelini Ventures € 300 Million Commitment GlobeNewswire

Angelini unveils $293m healthcare venture fund - - Global Venturing

Angelini unveils $293m healthcare venture fund - Global Venturing

Angelini Ventures co-leads Series A financing in Neumirna Therapeutics - PharmaTimes

Angelini Ventures co-leads Series A financing in Neumirna Therapeutics PharmaTimes

Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders - BioSpace

Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders BioSpace

Angelini Ventures leads Nuclidium’s €84 million funding round - Startupbusiness.it

Angelini Ventures leads Nuclidium’s €84 million funding round Startupbusiness.it

60 million dollar round for CoMind with Angelini Ventures - Startupbusiness.it

60 million dollar round for CoMind with Angelini Ventures Startupbusiness.it

New round for Serenis, €12 million led by Angelini Ventures - Startupbusiness.it

New round for Serenis, €12 million led by Angelini Ventures Startupbusiness.it

Top Angelini Ventures Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant